CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemcitabine in Patients with Resected Pancreatic Cancer
Kyung-Hun Lee, Eui Kyu Chie, Seock-Ah Im, Jee Hyun Kim, Jihyun Kwon, Sae-Won Han, Do-Youn Oh, Jin-Young Jang, Jae-Sung Kim, Tae-You Kim, Yung-Jue Bang, Sun Whe Kim, Sung W. Ha
Cancer Research and Treatment. 2021;53(4):1096-1103.   Published online 2020 December 30    DOI: https://doi.org/10.4143/crt.2020.928

Excel Download

Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemcitabine in Patients with Resected Pancreatic Cancer
Cancer Research and Treatment. 2021;53(4):1096-1103   Crossref logo
Link1 Link2 Link3

A randomized phase II trial of adjuvant chemotherapy with uracil/tegafur and gemcitabine versus gemcitabine alone in patients with resected pancreatic cancer
Cancer. 2008;113(9):2448-2456   Crossref logo
Link1 Link2

3540 POSTER Postoperative adjuvant gemcitabine plus oxaliplatin (GemOx) chemotherapy followed by chemoradiation in patients with pancreatic carcinoma: mature results of a multicenter phase II study
European Journal of Cancer Supplements. 2007;5(4):271   Crossref logo
Link1 Link2

P382 A randomized phase II trial of sequential gemcitabine plusvinorelbine followed by gemcitabine plus Ifosfamide versus gemcitabine plus cisplatin in the treatment of chemonaïve patients with stage III and IV non-small cell lung cancer (NSCLC)
Lung Cancer. 2005;49:S271   Crossref logo
Link1 Link2

Randomized Phase II Trial of Gemcitabine and Cisplatin (GP) versus Docetaxel and Cisplatin (TP) as Induction Chemotherapy followed by Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
International Journal of Radiation Oncology*Biology*Physics. 2020;108(3):S106   Crossref logo
Link1 Link2

Adjuvant therapy with gemcitabine and stereotactic body radiation therapy versus gemcitabine alone for resected stage ii pancreatic cancer: a prospective, randomized, open-label, single center trial
HPB. 2019;21:S316-S317   Crossref logo
Link1 Link2

Chemoradiotherapy with concurrent gemcitabine and cisplatin with or without sequential chemotherapy with gemcitabine/cisplatin vs chemoradiotherapy with concurrent 5-fluorouracil in patients with locally advanced pancreatic cancer – a multi-centre randomised phase II study
British Journal of Cancer. 2009;101(11):1853-1859   Crossref logo
Link1 Link2 Link3

Randomized Phase III Trial Comparing Cisplatin/Gemcitabine/Vinorelbine to Cisplatin/Gemcitabine or Cisplatin/Vinorelbine in Patients with Advanced NSCLC
Clinical Lung Cancer. 1999;1(2):94-95   Crossref logo
Link1 Link2

Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for locally advanced pancreatic cancer
Cancer Chemotherapy and Pharmacology. 2012;70(3):381-389   Crossref logo
Link1 Link2 Link3

Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer
European Journal of Cancer. 2017;72:S77   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.